RxDoctor Payments Data

Darcy Schroeder, PA

Physician Assistant · Lima, OHNPI 1801075023

Payments from drug & device makers

$4,830in general payments, 2019–2025

Across 289 payments — averaging $16.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$1K
  • Amgen$652
  • Johnson & Johnson$425
  • Novartis$376
  • Astellas Pharma US Inc$296
  • Merck$239
  • plus $2K from 23 others

What the payments were for

  • Food & beverage$4,56995%
  • Education$2615%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,830 in reported general payments places this provider in the 90th percentile of 4,098 physician assistant providers in Ohio.

See all physician assistant providers in Ohio

Medicare billing

Part B allowed, 2024
$40,669
Medicare patients
364
Services billed
638

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor126$74,670
VascepaIcosapent Ethyl11$5,181
Ranolazine ErRanolazine23$3,362
Midodrine Hcl19$1,996
Metoprolol Succinate157$1,779
Atorvastatin Calcium211$1,542
Potassium Chloride43$1,488
ClopidogrelClopidogrel Bisulfate111$1,189
Isosorbide Mononitrate ErIsosorbide Mononitrate64$1,120
Prasugrel Hcl13$883
Bumetanide24$790
Diltiazem 24hr Er (Cd)Diltiazem Hcl17$726
Rosuvastatin Calcium58$675
Nitroglycerin78$624
Metoprolol Tartrate111$500

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBrilinta$169$74,670126 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,098 physician assistant providers in Ohio.

Other physician assistant in Lima

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →